March 6, 2024

MOG Antibodies Restricted to CSF in Children With Inflammatory CNS Disorders

GOGemma Olivé-CireraHospital de Sant Pau ABArlette L. BruijstensErasmus MC EFElianet FonsecaHospital Sant Joan de Déu Barcelona

Key Points

Key points are not available for this paper at this time.

Abstract

To assess the clinical significance of myelin oligodendrocyte glycoprotein antibodies (MOG-abs) restricted to CSF in children with inflammatory CNS disorders.

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Olivé-Cirera et al. (Wed,) studied this question.

synapsesocial.com/papers/68e75695b6db6435876ce564 https://doi.org/https://doi.org/10.1212/wnl.0000000000209199

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates2005 · 488 citations
2Development and reliability of a system to classify gross motor function in children with cerebral palsy1997 · 6,759 citations
3Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder2021 · 90 citations
4Antibodies to MOG in CSF only: pathological findings support the diagnostic value2021 · 24 citations
5International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions2013 · 1,117 citations

AI에게 질문

Bookmark

View Full Paper